| Jennifer Mcniff, MD | |
|
15 York St, Lmp 5031, New Haven, CT 06510-3221 | |
| (203) 785-4091 | |
| (203) 785-3315 |
| Full Name | Jennifer Mcniff |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 38 Years |
| Location | 15 York St, New Haven, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619951902 | NPI | - | NPPES |
| 001325275 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 032527 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Yale-new Haven Hospital | New haven, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Yale University | 9436061736 | 2241 |
News Archive
The Justice Department makes clear its intent to appeal the Virginia federal court decision striking at the health overhaul's individual mandate. Meanwhile, news outlets explore the reach of that decision, noting that it may be more narrow than the reaction immediately following its release would indicate. Also explored: the next steps for this central provision within the health law and how it has become the sweeping overhaul's "central villain."
Generex Biotechnology Corporation today announced its receipt of a decision by the NASDAQ Listing Qualifications Panel, which granted the Company's request for continued listing of the Company's common stock on The NASDAQ Stock Market on an interim basis, subject to certain conditions subsequent which are described in the Form 8-K Current Report filed by the Company with the Securities and Exchange Commission on EDGAR earlier today.
Female blood-feeding mosquitoes, some species of which can transmit deadly diseases such as malaria and dengue to humans, largely find their human blood meals by detecting carbon dioxide emitted when people exhale.
Modern scientific understanding has considered multiple sclerosis (MS) to be a disease controlled by the T cell, a type of white blood cell. Research has shown that in MS, T cells inappropriately attack myelin, the protective layer of fat covering nerves in the central nervous system, exposing them to damage.
To add to existing CRISPR-based nucleic acid detection protocols, a team of researchers recently established a new SARS-CoV-2 detection protocol based on their previously reported platform - CDetection (Cas12b-mediated DNA detection). They combined nucleic-acid amplification methods and sample treatment protocols with CDetection and established an integrated nucleic acid detection platform called CRISPR-assisted detection or CASdetec. CASdetec has a detection limit of 1×104 copies/mL for SARS-CoV-2 pseudovirus, without any observed cross-reactivity.
› Verified 2 days ago
| Entity Name | Yale University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205822236 PECOS PAC ID: 9436061736 Enrollment ID: O20031105000015 |
News Archive
The Justice Department makes clear its intent to appeal the Virginia federal court decision striking at the health overhaul's individual mandate. Meanwhile, news outlets explore the reach of that decision, noting that it may be more narrow than the reaction immediately following its release would indicate. Also explored: the next steps for this central provision within the health law and how it has become the sweeping overhaul's "central villain."
Generex Biotechnology Corporation today announced its receipt of a decision by the NASDAQ Listing Qualifications Panel, which granted the Company's request for continued listing of the Company's common stock on The NASDAQ Stock Market on an interim basis, subject to certain conditions subsequent which are described in the Form 8-K Current Report filed by the Company with the Securities and Exchange Commission on EDGAR earlier today.
Female blood-feeding mosquitoes, some species of which can transmit deadly diseases such as malaria and dengue to humans, largely find their human blood meals by detecting carbon dioxide emitted when people exhale.
Modern scientific understanding has considered multiple sclerosis (MS) to be a disease controlled by the T cell, a type of white blood cell. Research has shown that in MS, T cells inappropriately attack myelin, the protective layer of fat covering nerves in the central nervous system, exposing them to damage.
To add to existing CRISPR-based nucleic acid detection protocols, a team of researchers recently established a new SARS-CoV-2 detection protocol based on their previously reported platform - CDetection (Cas12b-mediated DNA detection). They combined nucleic-acid amplification methods and sample treatment protocols with CDetection and established an integrated nucleic acid detection platform called CRISPR-assisted detection or CASdetec. CASdetec has a detection limit of 1×104 copies/mL for SARS-CoV-2 pseudovirus, without any observed cross-reactivity.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Mcniff, MD 15 York St, Lmp 5031, New Haven, CT 06510-3221 Ph: (203) 785-4091 | Jennifer Mcniff, MD 15 York St, Lmp 5031, New Haven, CT 06510-3221 Ph: (203) 785-4091 |
News Archive
The Justice Department makes clear its intent to appeal the Virginia federal court decision striking at the health overhaul's individual mandate. Meanwhile, news outlets explore the reach of that decision, noting that it may be more narrow than the reaction immediately following its release would indicate. Also explored: the next steps for this central provision within the health law and how it has become the sweeping overhaul's "central villain."
Generex Biotechnology Corporation today announced its receipt of a decision by the NASDAQ Listing Qualifications Panel, which granted the Company's request for continued listing of the Company's common stock on The NASDAQ Stock Market on an interim basis, subject to certain conditions subsequent which are described in the Form 8-K Current Report filed by the Company with the Securities and Exchange Commission on EDGAR earlier today.
Female blood-feeding mosquitoes, some species of which can transmit deadly diseases such as malaria and dengue to humans, largely find their human blood meals by detecting carbon dioxide emitted when people exhale.
Modern scientific understanding has considered multiple sclerosis (MS) to be a disease controlled by the T cell, a type of white blood cell. Research has shown that in MS, T cells inappropriately attack myelin, the protective layer of fat covering nerves in the central nervous system, exposing them to damage.
To add to existing CRISPR-based nucleic acid detection protocols, a team of researchers recently established a new SARS-CoV-2 detection protocol based on their previously reported platform - CDetection (Cas12b-mediated DNA detection). They combined nucleic-acid amplification methods and sample treatment protocols with CDetection and established an integrated nucleic acid detection platform called CRISPR-assisted detection or CASdetec. CASdetec has a detection limit of 1×104 copies/mL for SARS-CoV-2 pseudovirus, without any observed cross-reactivity.
› Verified 2 days ago
Robert E Tigelaar, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 15 York St, Dermatology, Lci Room 609, New Haven, CT 06510 Phone: 203-785-4632 Fax: 203-785-3315 | |
Marianna Freudzon, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 333 Cedar St, Yusm Department Of Dermatology, New Haven, CT 06510 Phone: 203-785-4632 | |
Michael Girardi, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 15 York St, New Haven, CT 06510 Phone: 203-785-4632 Fax: 203-785-3315 | |
Dr. Noah Hornick, MD, PHD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 150 Sargent Dr Ste 2, New Haven, CT 06511 Phone: 203-503-3000 | |
Antonio Subtil Deoliveira Jr., MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 800 Howard Ave, Yale Physicians Building, New Haven, CT 06519 Phone: 203-785-2140 | |
Dr. Mary Escherich Laird, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2 Church St S, New Haven, CT 06519 Phone: 203-785-4445 Fax: 203-776-6188 | |
Leonard M Milstone, MD Dermatology Medicare: Medicare Enrolled Practice Location: 800 Howard Ave, Yale Physicians Building, New Haven, CT 06519 Phone: 203-785-2140 |